Financhill
Back

Array Technologies Vs. Biomarin Pharmaceutical Industry Stock Comparison

Sell
32

ARRY
Array Technologies

Last Price:
6.45
Seasonality Move:
-7.01%
Sell
32

BMRN
Biomarin Pharmaceutical

Last Price:
68.71
Seasonality Move:
11.99%
Sell
32
Array Technologies (ARRY) is a Sell

Is Array Technologies a Buy, Sell or Hold?

  • The current Array Technologies [ARRY] share price is $6.48. The Score for ARRY is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
  • ARRY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
32
Biomarin Pharmaceutical (BMRN) is a Sell

Is Biomarin Pharmaceutical a Buy, Sell or Hold?

  • The current Biomarin Pharmaceutical [BMRN] share price is $68.96. The Score for BMRN is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
  • BMRN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ARRY Stock Price Chart

What is Array Technologies's stock price today?

  • The Array Technologies share price today is $6.48
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ARRY is experiencing slight selling pressure.

BMRN Stock Price Chart

What is Biomarin Pharmaceutical's stock price today?

  • The Biomarin Pharmaceutical share price today is $68.96
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMRN is experiencing slight buying pressure.

ARRY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.19 Sell
Relative Strength Index (14 RSI): 45.92 Sell
Chaikin Money Flow: -1078856 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (6.2 - 6.84) Sell
Bollinger Bands (100): (6.79 - 12.13) Sell

BMRN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -4.13 Sell
Relative Strength Index (14 RSI): 29.24 Sell
Chaikin Money Flow: 270547 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (67.81 - 83.61) Sell
Bollinger Bands (100): (75.16 - 88.58) Sell

ARRY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 6.53 Sell
20-day SMA: 6.54 Sell
50-day SMA: 7.15 Sell
200-day SMA: 11.6 Sell
8-day EMA: 6.48 Sell
20-day EMA: 6.58 Sell
50-day EMA: 7.41 Sell
200-day EMA: 11.3 Sell

BMRN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 69.69 Sell
20-day SMA: 72.88 Sell
50-day SMA: 82.11 Sell
200-day SMA: 85.37 Sell
8-day EMA: 69.73 Sell
20-day EMA: 73.23 Sell
50-day EMA: 78.72 Sell
200-day EMA: 84.16 Sell

Array Technologies Earnings Growth & ARRY Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.12 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.37 per share, and an increase next year of $0.31 per share.

Biomarin Pharmaceutical Earnings Growth & BMRN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.29 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.19 per share, and an increase next year of $1.04 per share.

Array Technologies Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Biomarin Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):